drugset / Trial / NCT02888444
Smoking Relapse Prevention Among COPD Ex-smokers
RandomizedParallel-groupTriple-blindPrevention
Summary
A placebo-controlled trial to determine whether recent ex-smokers with COPD who successfully stop smoking after taking varenicline are less likely to relapse back to smoking if they continue using varenicline for a further 12 weeks
Timeline
- Start
- 2017-07-31
- Primary completion
- 2018-04-13
- Completion
- 2018-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Varenicline | Small molecule | 0.5 mg | — |